Preserving the Balance in Stroke Prevention: Brain, Heart and Kidneys (symposium Summary Sponsored by Bayer)
Volume 5 Issue 1, pages 52-61
Received – 24th July 2019, Accepted – 26th July 2019
Graeme J. Hankey
Medical School, The University of Western Australia, Perth, Australia.
University Clinic Schleswig-Holstein, Department für Rhythmology and Electrophysiology, Arnold-Heller-Str. 3, 24105 Kiel, Germany
McMaster University / Population Health Research Institute, 237 Barton Street East, HGH-DBCVSRI C4-120, Hamilton, Ontario, L8L 2X2, Canada.
Corresponding Author: Allison Kirsop – email@example.com
Stroke is the second leading cause of death after ischaemic heart disease, and the second leading cause of Disability Adjusted Life Years (DALYs) lost globally. A holistic approach to the prevention and management of stroke can reduce stroke-related mortality and morbidity.The association between diabetes, atrial fibrillation, and renal disease as risk factors for stroke are discussed in this meeting summary. The results of phase 3 trials for anticoagulation therapy are reviewed and presented in the context of defining high-risk patients for stroke and cardiovascular disease.
Key words: Atrial Fibrillation, Cardiovascular Disease, Chronic Kidney Disease, Diabetes, Ischaemic Heart Disease, Stroke
Acknowledgements: We thank Dr Allison Kirsop and Oruen Ltd. for editorial assistance in the preparation of this manuscript.